[1] |
LIN Zhaoping, CHEN Chaofeng, GAO Jing, HUANG Cong, YU Bo, SHEN Changbing.
Chronic disease management of psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(3): 226-230.
|
[2] |
SONG Pingping, WANG Na, DU Donghong, LIU Jing, RAN Delin, YANG Baoqi.
Generalized pustular psoriasis successfully treated with spesolimab: two cases report
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(2): 127-129.
|
[3] |
ZHANG Meng, SUN Yuexin, LI Zhiyu, BAO Jun, ZHOU Ying.
Acute generalized pustular psoriasis treated with spesolimab: two cases report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(1): 37-42.
|
[4] |
XU Ruoxin, LI Jingyi.
Research progress on the mechanism of neurotransmitter receptors mediating immune disorders in atopic dermatitis
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(1): 73-78.
|
[5] |
XUE Huaiyu, JI Huilin, ZHU Yidi, LIU Qingna, WEI Zhiping.
Correlation between adipokine, BMI and metabolic syndrome in the patients with psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(9): 612-617.
|
[6] |
Dilinuer TAXIMAIMAITI, Palida ABULIZI.
Efficacy and safety of abrocitinib and dupilumab in the treatment of moderate to severe atopic dermatitis
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(8): 533-537.
|
[7] |
GUO Shuting, LI Ruijie, YANG Meili, JIN Yaqiao, ZHAO Yiyu, ZHANG Lu, HAN Hui, HAO Yong.
Effect of dupilumab on Staphylococcus aureus colonization in adults with moderate to severe atopic dermatitis
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(8): 545-549.
|
[8] |
WANG Wansi, SHEN Jiaqing, LIU Yi.
Update of TIGIT and related skin diseases
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(5): 377-382.
|
[9] |
XU Yuanyuan, GUO Linghong, WU Shuwei, ZHANG Ting, ZHANG Lu, JIANG Xian.
Causal associations between three atopic diseases and alopecia areata: a two-sample Mendelian randomization study
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(4): 239-244.
|
[10] |
CHEN Xueqin, SONG Zhiqiang.
Update of skin tissue-resident memory T cells and inflammatory skin diseases recurrence
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(4): 292-296.
|
[11] |
HAN Jinghong, LIU Hong.
Two children with refractory atopic dermatitis successfully treated with Janus kinase inhibitors
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 190-192.
|
[12] |
CHANG Jiayu, QI Miao, WANG Yimin, LI Yongxi, SHI Tongxin.
Bullous pemphigoid occurred in a patient with severe plaque psoriasis treated with secukinumab: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 199-201.
|
[13] |
XU Yang, ZHAN Weisheng, ZHAO Juhua.
Efficacy and safety of deucravacitinib in the treatment of moderate-to-severe plaque psoriasis: a meta-analysis
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(2): 89-94.
|
[14] |
CUI Yinling, ZHENG Chunzhi, YU Yongmei, LIU Hong.
Palmoplantar psoriasis resistant to secukinumab successfully treated with tofacitinib: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(2): 134-136.
|
[15] |
DENG Yazhi, KANG Xiaojing, DING Yuan.
Update of correlation between psoriasis and malignant tumors
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(2): 139-144.
|